NYSE:BAX - Baxter International Stock Price, Price Target & More

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International announced a quarterly dividend on Tuesday, July 17th. Investors of record on Friday, August 31st will be paid a dividend of $0.19 per share on Monday, October 1st. This represents a $0.76 dividend on an annualized basis and a yield of 1.01%. The ex-dividend date is Thursday, August 30th. View Baxter International's Dividend History.

Baxter International declared that its board has initiated a share buyback program on Wednesday, February 21st 2018, which permits the company to repurchase $1,500,000,000.00 in shares, according to EventVestor. This repurchase authorization permits the company to buy shares of its stock through open market purchases. Shares repurchase programs are usually a sign that the company's board believes its stock is undervalued.

Baxter International Inc (NYSE:BAX) issued its quarterly earnings results on Thursday, April, 26th. The medical instruments supplier reported $0.70 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.62 by $0.08. The medical instruments supplier had revenue of $2.68 billion for the quarter, compared to analyst estimates of $2.62 billion. Baxter International had a return on equity of 15.70% and a net margin of 7.75%. The company's revenue for the quarter was up 8.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.58 EPS. View Baxter International's Earnings History.

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, July, 26th 2018. View Earnings Estimates for Baxter International.

Baxter International updated its FY18 earnings guidance on Thursday, April, 26th. The company provided earnings per share (EPS) guidance of $2.85-2.93 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.78. The company issued revenue guidance of $11.3-11.4 billion, compared to the consensus revenue estimate of $11.25 billion.Baxter International also updated its Q2 guidance to $0.69-0.71 EPS.

16 analysts have issued 1 year price objectives for Baxter International's stock. Their predictions range from $62.00 to $83.00. On average, they anticipate Baxter International's stock price to reach $72.7333 in the next year. This suggests that the stock has a possible downside of 3.0%. View Analyst Ratings for Baxter International.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 6 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Some companies that are related to Baxter International include 3M (MMM), Becton Dickinson and (BDX), Stryker (SYK), Boston Scientific (BSX), FRESENIUS SE &/S (FSNUY), ABIOMED (ABMD), ResMed (RMD), Teleflex (TFX), Dexcom (DXCM), Hill-Rom (HRC), ICU Medical (ICUI), Insulet (PODD), Globus Medical (GMED), Haemonetics (HAE) and Penumbra (PEN).

Headlines about BAX stock have been trending somewhat positive recently, Accern reports. Accern rates the sentiment of news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Baxter International earned a media sentiment score of 0.02 on Accern's scale. They also gave media headlines about the medical instruments supplier an impact score of 45.38 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

Baxter International's stock is owned by many different of retail and institutional investors. Top institutional investors include Calamos Advisors LLC (0.25%), Bank of Montreal Can (0.11%), Gateway Investment Advisers LLC (0.08%), Huntington National Bank (0.08%), Boston Advisors LLC (0.07%) and NN Investment Partners Holdings N.V. (0.05%). Company insiders that own Baxter International stock include Albert P L Stroucken, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including NN Investment Partners Holdings N.V., Bank of Montreal Can, Assenagon Asset Management S.A., Hartford Investment Management Co., Ipswich Investment Management Co. Inc., Westpac Banking Corp, Gateway Investment Advisers LLC and Tokio Marine Asset Management Co. Ltd.. Company insiders that have sold Baxter International company stock in the last year include Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

BAX stock was bought by a variety of institutional investors in the last quarter, including Sit Investment Associates Inc., Handelsbanken Fonder AB, Boston Advisors LLC, Cornerstone Wealth Management LLC, Huntington National Bank, Calamos Advisors LLC, Municipal Employees Retirement System of Michigan and Gulf International Bank UK Ltd. View Insider Buying and Selling for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $75.00.

Baxter International has a market capitalization of $40.00 billion and generates $10.56 billion in revenue each year. The medical instruments supplier earns $717 million in net income (profit) each year or $2.48 on an earnings per share basis. Baxter International employs 47,000 workers across the globe.

Baxter International's mailing address is One Baxter Parkway, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]axter.com.